The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...

The GLP-1 arena has turned into a boxing match between heavyweights Novo Nordisk and Eli Lilly as the two pharma giants ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!

Rybelsus, the oral form of Semaglutide launched by Novo Nordisk in January 2022, has grown from Rs 26 crore to Rs 412 crore, ...

The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate hearing next week to defend the ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Theratechnologies entered a definitive agreement to be acquired by Future Pak. Find out why do not expect to see THTX stock ...

We spoke with Tahiri about the evolution of nutrition innovation, the importance of understanding consumers on a deeper level ...